Back

Favipiravir In Adults with Moderate to Severe COVID-19: A Phase 3 Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial.

2021-11-09 infectious diseases Title + abstract only
View on medRxiv
Show abstract

AimTo assess the efficacy and safety of favipiravir in adults with moderate to severe coronavirus disease 2019 (COVID-19). MethodsIn this randomized, double-blind, multicenter, phase 3 trial, adults (21-80 years) with real-time reverse transcriptase polymerase chain reaction (rRT-PCR) confirmed SARS-CoV-2 infection and presenting with moderate to severe COVID-19 and requiring hospitalization were randomized 1:1 to oral favipiravir (day 1: 1800 mg BID and days 2-10: 800 mg BID) (FPV) plus standa...

Predicted journal destinations

1
PLOS ONE
1737 training papers
Top 59% 10.0%
2
Clinical Microbiology and Infection
54 training papers
#1 7.1%
3
Clinical Infectious Diseases
219 training papers
Top 4% 7.1%
4
Scientific Reports
701 training papers
Top 53% 5.4%
5
Open Forum Infectious Diseases
124 training papers
Top 1% 5.4%
6
The Journal of Infectious Diseases
137 training papers
Top 4% 3.5%
7
Journal of Medical Virology
95 training papers
Top 3% 3.5%
8
International Journal of Infectious Diseases
115 training papers
Top 4% 3.5%
9
Frontiers in Medicine
99 training papers
Top 4% 3.5%
10
BMJ Open
553 training papers
Top 42% 3.3%
11
JAMA Network Open
125 training papers
Top 6% 2.8%
12
BMJ
49 training papers
Top 2% 1.8%
13
Nature Communications
483 training papers
Top 40% 1.8%
14
PLOS Medicine
95 training papers
Top 7% 1.8%
15
BMC Infectious Diseases
110 training papers
Top 9% 1.8%
16
Journal of Infection
64 training papers
Top 4% 1.4%
17
New England Journal of Medicine
49 training papers
Top 2% 1.4%
18
Frontiers in Pharmacology
27 training papers
Top 2% 1.2%
19
Med
26 training papers
Top 0.4% 1.2%
20
BMC Medicine
155 training papers
Top 25% 1.1%
21
Journal of Clinical Virology
54 training papers
Top 5% 1.1%
22
Nature Medicine
88 training papers
Top 11% 1.0%
23
The Lancet Infectious Diseases
57 training papers
Top 6% 1.0%
24
Journal of Infection and Public Health
15 training papers
Top 0.3% 1.0%
25
Emerging Microbes & Infections
20 training papers
Top 0.7% 0.9%
26
Frontiers in Immunology
140 training papers
Top 12% 0.9%
27
eBioMedicine
82 training papers
Top 11% 0.9%
28
eClinicalMedicine
55 training papers
Top 4% 0.9%
29
Journal of Clinical Microbiology
77 training papers
Top 7% 0.9%
30
GeroScience
22 training papers
Top 3% 0.7%